Physiomics Plc (LON:PYC – Get Free Report)’s stock price hit a new 52-week low on Monday . The stock traded as low as GBX 0.41 ($0.01) and last traded at GBX 0.41 ($0.01), with a volume of 1370689 shares traded. The stock had previously closed at GBX 0.42 ($0.01).
Physiomics Trading Down 3.3 %
The business’s 50-day simple moving average is GBX 0.76 and its 200-day simple moving average is GBX 0.71. The company has a market capitalization of £841,167.83, a PE ratio of -0.92 and a beta of 1.69.
Physiomics (LON:PYC – Get Free Report) last issued its earnings results on Thursday, March 6th. The company reported GBX (0.12) ($0.00) earnings per share (EPS) for the quarter. Physiomics had a negative return on equity of 127.68% and a negative net margin of 106.80%. Sell-side analysts forecast that Physiomics Plc will post -0.13 EPS for the current fiscal year.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Recommended Stories
- Five stocks we like better than Physiomics
- Are Penny Stocks a Good Fit for Your Portfolio?
- How to Protect Your Portfolio When Inflation Is Rising
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.